These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15834642)

  • 1. Factors associated with drug-induced visual hallucinations in Parkinson's disease.
    Papapetropoulos S; Argyriou AA; Ellul J
    J Neurol; 2005 Oct; 252(10):1223-8. PubMed ID: 15834642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of dementia and visual hallucinations in tremor and non-tremor dominant Parkinson's disease.
    Rana AQ; Vaid HM; Edun A; Dogu O; Rana MA
    J Neurol Sci; 2012 Dec; 323(1-2):158-61. PubMed ID: 23062324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hallucinations in Parkinson's disease: cross-sectional study.
    Svetel M; Smiljković T; Pekmezović T; Kostić V
    Acta Neurol Belg; 2012 Mar; 112(1):33-7. PubMed ID: 22427287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of hallucinations and delusions in Parkinson's disease.
    Holroyd S; Currie L; Wooten GF
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):734-8. PubMed ID: 11385005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors.
    Fénelon G; Mahieux F; Huon R; Ziégler M
    Brain; 2000 Apr; 123 ( Pt 4)():733-45. PubMed ID: 10734005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor visual discrimination and visual hallucinations in Parkinson's disease.
    Diederich NJ; Goetz CG; Raman R; Pappert EJ; Leurgans S; Piery V
    Clin Neuropharmacol; 1998; 21(5):289-95. PubMed ID: 9789709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.
    Giladi N; Treves TA; Paleacu D; Shabtai H; Orlov Y; Kandinov B; Simon ES; Korczyn AD
    J Neural Transm (Vienna); 2000; 107(1):59-71. PubMed ID: 10809404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for visual hallucinations in patients with Parkinson's disease.
    Gama RL; de Bruin VM; de Bruin PF; Távora DG; Lopes EM; Jorge IF; Bittencourt LR; Tufik S
    Neurol Res; 2015 Feb; 37(2):112-6. PubMed ID: 25002179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of associated clinical variables and phenomenology of hallucinations in Parkinson's].
    Cubo E; González M; Aguilar A; Quintana S
    Neurologia; 2006; 21(1):12-8. PubMed ID: 16525921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing an aetiological model of visual hallucinations in Parkinson's disease.
    Gallagher DA; Parkkinen L; O'Sullivan SS; Spratt A; Shah A; Davey CC; Bremner FD; Revesz T; Williams DR; Lees AJ; Schrag A
    Brain; 2011 Nov; 134(Pt 11):3299-309. PubMed ID: 21921019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson's disease.
    Merims D; Shabtai H; Korczyn AD; Peretz C; Weizman N; Giladi N
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1447-53. PubMed ID: 15480845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between visual hallucinations and REM sleep behavior disorder in patients with Parkinson's disease.
    Meral H; Aydemir T; Ozer F; Ozturk O; Ozben S; Erol C; Cetin S; Hanoglu L; Ozkayran T; Yilsen M
    Clin Neurol Neurosurg; 2007 Dec; 109(10):862-7. PubMed ID: 17913346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired visual acuity as a risk factor for visual hallucinations in Parkinson's disease.
    Matsui H; Udaka F; Tamura A; Oda M; Kubori T; Nishinaka K; Kameyama M
    J Geriatr Psychiatry Neurol; 2006 Mar; 19(1):36-40. PubMed ID: 16449759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients.
    Goetz CG; Wuu J; Curgian L; Leurgans S
    Mov Disord; 2006 Feb; 21(2):267-70. PubMed ID: 16161144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease.
    Nicoletti A; Mostile G; Nicoletti G; Arabia G; Iliceto G; Lamberti P; Marconi R; Morgante L; Barone P; Quattrone A; Zappia M
    J Neurol; 2016 May; 263(5):888-894. PubMed ID: 26964541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body side and predominant motor features at the onset of Parkinson's disease are linked to motor and nonmotor progression.
    Baumann CR; Held U; Valko PO; Wienecke M; Waldvogel D
    Mov Disord; 2014 Feb; 29(2):207-13. PubMed ID: 24105646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral atrophy in Parkinson's disease patients with visual hallucinations.
    Ramírez-Ruiz B; Martí MJ; Tolosa E; Giménez M; Bargalló N; Valldeoriola F; Junqué C
    Eur J Neurol; 2007 Jul; 14(7):750-6. PubMed ID: 17594330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease.
    Llebaria G; Pagonabarraga J; Martínez-Corral M; García-Sánchez C; Pascual-Sedano B; Gironell A; Kulisevsky J
    Mov Disord; 2010 Dec; 25(16):2785-91. PubMed ID: 20960483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Two cases of Parkinson's disease in which visual hallucinations disappeared after cataract surgery].
    Matsui H; Udaka F; Oda M; Kubori T; Nishinaka K; Kameyama M
    No To Shinkei; 2004 Apr; 56(4):351-4. PubMed ID: 15237728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hallucinations in Parkinson's disease: a follow-up study.
    de Maindreville AD; Fénelon G; Mahieux F
    Mov Disord; 2005 Feb; 20(2):212-7. PubMed ID: 15390044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.